Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	65147
Country	Italy

Received	2021-02-28 15:50
Peer-Review Started	2021-02-28 15:59
To Make the First Decision
Return for Revision	2021-04-06 04:46
Revised	2021-04-09 16:28
Second Decision	2021-05-25 14:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-05-25 15:15
Articles in Press	2021-05-25 15:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-06-10 00:23
Typeset the Manuscript	2021-06-18 01:08
Publish the Manuscript Online	2021-06-18 13:06

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Opinion Review
Article Title	Borderline resectable pancreatic cancer: Certainties and controversies
Manuscript Source	Invited Manuscript
All Author List	Gennaro Nappo, Greta Donisi and Alessandro Zerbi
ORCID	Author(s) ORCID Number Gennaro Nappo http://orcid.org/0000-0002-6048-898X Greta Donisi http://orcid.org/0000-0002-5873-6577 Alessandro Zerbi http://orcid.org/0000-0002-9176-0448​
Funding Agency and Grant Number
Corresponding Author	Gennaro Nappo, MD, Surgeon, Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, Rozzano 20089, Italy. gennaro.nappo@humanitas.it
Key Words	Borderline resectable pancreatic cancer; Pancreatic cancer; Neoadjuvant treatment; Chemotherapy; Radiotherapy; Pancreatic tumour
Core Tip	The term borderline resectable identifies a tumour with an aggressive biological behaviour, on which a neoadjuvant approach instead of upfront surgery one should be preferred, in order to obtain a radical resection (R0) and to avoid an early recurrence after surgery. The aim of this review is to critically analyze the available literature on this topic.
Publish Date	2021-06-18 13:06
Citation	Nappo G, Donisi G, Zerbi A. Borderline resectable pancreatic cancer: Certainties and controversies. World J Gastrointest Surg 2021; 13(6): 516-528
URL	https://www.wjgnet.com/1948-9366/full/v13/i6/516.htm
DOI	https://dx.doi.org/10.4240/wjgs.v13.i6.516

Full Article (PDF)	WJGS-13-516.pdf
Full Article (Word)	WJGS-13-516.docx
Manuscript File	65147-Review-FilipodiaCL .docx
Answering Reviewers	65147-Answering reviewers.pdf
Audio Core Tip	65147-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	65147-Conflict-of-interest statement.pdf
Copyright License Agreement	65147-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65147-Language certificate.pdf
Peer-review Report	65147-Peer-review(s).pdf
Scientific Misconduct Check	65147-Scientific misconduct check.pdf
Scientific Editor Work List	65147-Scientific editor work list.pdf
CrossCheck Report	65147-CrossCheck report.pdf